Summary:
This study will help to evaluate the safety, tolerability and pharmacokinetics of an Investigational Medication
for the treatment of Psoriasis (Mild, Moderate & Severe)
Qualified Participants Must:
• Be a male or female aged 18-70 years
•
Diagnosed with Psoriasis (Mild, Moderate &
• Severe) at least 6 months prior the screening
Qualified Participants May Receive:
Qualified participants will receive the study medication at no cost, and a fair economic compensation for your travel expenses.